Novo A/S
Latest statistics and disclosures from Novo Holdings A/S's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BN, EWTX, ASML, MIRM, CRM, and represent 46.78% of Novo Holdings A/S's stock portfolio.
- Added to shares of these 5 stocks: MPLT (+$65M), BN (+$54M), FDMT (+$12M), APGE (+$5.3M), ELVN.
- Started 1 new stock position in MPLT.
- Reduced shares in these 7 stocks: VTI (-$341M), MRUS (-$71M), RXRX (-$39M), ASML (-$34M), ZBIO (-$20M), VALN, GLTO.
- Sold out of its positions in GLTO, RXRX, VTI, MRUS.
- Novo Holdings A/S was a net seller of stock by $-368M.
- Novo Holdings A/S has $1.3B in assets under management (AUM), dropping by -17.01%.
- Central Index Key (CIK): 0001388325
Tip: Access up to 7 years of quarterly data
Positions held by Novo A/S consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 24 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Brookfield Corp Cl A Ltd Vt Sh (BN) | 12.5 | $160M | +50% | 3.5M | 45.89 |
|
| Edgewise Therapeutics (EWTX) | 10.3 | $133M | 5.4M | 24.82 |
|
|
| Asml Holding N V N Y Registry Shs (ASML) | 9.5 | $122M | -21% | 114k | 1069.86 |
|
| Mirum Pharmaceuticals (MIRM) | 7.8 | $100M | 1.3M | 78.99 |
|
|
| salesforce (CRM) | 6.8 | $88M | 330k | 264.91 |
|
|
| Crinetics Pharmaceuticals In (CRNX) | 5.9 | $76M | 1.6M | 46.55 |
|
|
| Miragen Therapeutics (VRDN) | 5.8 | $74M | 2.4M | 31.12 |
|
|
| Maplight Therapeutics (MPLT) | 5.0 | $65M | NEW | 3.7M | 17.57 |
|
| Zenas Biopharma (ZBIO) | 4.1 | $53M | -27% | 1.5M | 36.31 |
|
| Pharvaris N V (PHVS) | 3.8 | $49M | 1.8M | 27.75 |
|
|
| Apogee Therapeutics (APGE) | 3.3 | $43M | +14% | 570k | 75.48 |
|
| Vaxcyte (PCVX) | 3.3 | $42M | 916k | 46.14 |
|
|
| BioMarin Pharmaceutical (BMRN) | 3.0 | $39M | 660k | 59.43 |
|
|
| Arrivent Biopharma (AVBP) | 3.0 | $39M | 1.9M | 20.12 |
|
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 2.9 | $38M | 257k | 146.58 |
|
|
| Insmed Com Par $.01 (INSM) | 2.7 | $35M | 200k | 174.04 |
|
|
| Celldex Therapeutics Com New (CLDX) | 2.5 | $33M | 1.2M | 27.16 |
|
|
| 4d Molecular Therapeutics In (FDMT) | 2.1 | $27M | +82% | 3.7M | 7.50 |
|
| Bridgebio Oncology Therapeut Com New (BBOT) | 1.9 | $25M | 2.0M | 12.52 |
|
|
| Enliven Therapeutics (ELVN) | 1.8 | $23M | +3% | 1.5M | 15.40 |
|
| Valneva Se Sponsored Ads (VALN) | 1.6 | $20M | 2.3M | 8.82 |
|
|
| Lanzatech Global Com New (LNZA) | 0.2 | $2.2M | 158k | 13.76 |
|
|
| Marqeta Class A Com (MQ) | 0.2 | $2.1M | 442k | 4.75 |
|
|
| Io Biotech (IOBT) | 0.1 | $1.5M | 2.5M | 0.61 |
|
Past Filings by Novo Holdings A/S
SEC 13F filings are viewable for Novo Holdings A/S going back to 2014
- Novo Holdings A/S 2025 Q4 filed Feb. 17, 2026
- Novo Holdings A/S 2025 Q3 filed Nov. 14, 2025
- Novo Holdings A/S 2025 Q2 filed Aug. 14, 2025
- Novo Holdings A/S 2025 Q1 filed May 15, 2025
- Novo Holdings A/S 2024 Q4 filed Feb. 14, 2025
- Novo Holdings A/S 2024 Q3 filed Oct. 24, 2024
- Novo Holdings A/S 2024 Q2 restated filed Aug. 20, 2024
- Novo Holdings A/S 2024 Q1 filed May 15, 2024
- Novo Holdings A/S 2023 Q4 filed Feb. 14, 2024
- Novo Holdings A/S 2023 Q3 filed Nov. 14, 2023
- Novo Holdings A/S 2023 Q2 filed Aug. 14, 2023
- Novo Holdings A/S 2023 Q1 filed May 15, 2023
- Novo Holdings A/S 2022 Q4 filed Feb. 14, 2023
- Novo Holdings A/S 2022 Q3 filed Nov. 14, 2022
- Novo Holdings A/S 2022 Q2 filed Aug. 15, 2022
- Novo Holdings A/S 2022 Q1 restated filed May 27, 2022